
Eledon Pharmaceuticals, Inc.
ELDNNasdaqCIK 1404281HealthcareFiscal year ends Dec 31
Reports and events: 214 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-11-1617:02 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-054210 |
| 2020-10-1421:20 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-20-000795 |
| 2020-10-0616:45 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-264806 |
| 2020-09-1517:19 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-246314 |
| 2020-09-0416:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-240108 |
| 2020-08-1816:35 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-20-000691 |
| 2020-08-1419:38 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-040128 |
| 2020-06-1716:05 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001564590-20-029654 |
| 2020-05-1506:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-025631 |
| 2020-05-1506:02 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-025612 |
| 2020-05-1316:00 ET | 8-K | 5.07 Shareholder vote results | 0001564590-20-025038 |
| 2020-04-2306:03 ET | 8-K | 3.01 Delisting notice | 0001564590-20-018029 |
| 2020-03-3116:00 ET | DEF 14A | Proxy statementPeriod 2020-05-12 | 0001564590-20-014525 |
| 2020-03-2516:06 ET | S-1 | Registration statement | 0001193125-20-085060 |
| 2020-03-1706:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-011277 |
| 2020-03-1720:46 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-011260 |
| 2020-02-2517:04 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-20-000143 |
| 2020-02-2006:12 ET | 8-K/A | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-042564 |
| 2020-02-1916:11 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-041903 |
| 2020-02-0718:00 ET | 8-K | 3.01 Delisting notice | 0001564590-20-003758 |
| 2020-01-1606:32 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-20-008426 |
| 2019-11-1306:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-19-043080 |
| 2019-11-1318:01 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001564590-19-043039 |
| 2019-08-1316:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-19-031828 |
| 2019-08-1316:06 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001564590-19-031785 |
| 2019-08-0917:30 ET | 8-K | 3.01 Delisting notice | 0001193125-19-218112 |
| 2019-07-1216:05 ET | 8-K | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-19-193205 |
| 2019-06-0716:07 ET | S-1 | Registration statement | 0001193125-19-168171 |
| 2019-05-1516:30 ET | DEF 14A | Proxy statementPeriod 2019-07-11 | 0001564590-19-019430 |
| 2019-05-1416:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-19-019162 |
| 2019-05-1416:06 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001564590-19-019134 |
| 2019-05-0617:01 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-19-000328 |
| 2019-05-0216:24 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-135059 |
| 2019-04-3016:05 ET | 10-K/A | Annual report, amendedPeriod 2018-12-31 | 0001193125-19-129270 |
| 2019-04-2208:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-19-012158 |
| 2019-04-0507:32 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-19-020047 |
| 2019-03-2806:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-19-009676 |
| 2019-03-2817:53 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001564590-19-009631 |
| 2019-01-0812:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-19-000367 |
| 2018-11-1307:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-18-029134 |
| 2018-11-1317:45 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001564590-18-028982 |
| 2018-09-0416:38 ET | S-1/A | Registration statement, amended | 0001193125-18-266270 |
| 2018-08-0708:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-18-019667 |
| 2018-08-0717:43 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001564590-18-019519 |
| 2018-08-0118:00 ET | S-1 | Registration statement | 0001193125-18-233511 |
| 2018-06-1417:24 ET | 8-K | 5.07 Shareholder vote results | 0001564590-18-015631 |
| 2018-05-1516:22 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-18-000344 |
| 2018-05-1119:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-18-013100 |
| 2018-05-1119:19 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001564590-18-013090 |
| 2018-05-0217:12 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-18-000306 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.